All News

Amina Abubakar, PharmD, AAHIVP, discusses how her career journey led to independent pharmacy ownership and continuing pharmacy education for her peers.

Emerging evidence for finerenone showcases the drug’s impact on heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction.

Representatives from XiFin, a revenue cycle management and workflow automation company, discussed the best approaches for independent pharmacies to engage with patients.

Warning: Being an owner or an employee at an independent pharmacy is likely hazardous to your mental health. Stress and burnout are rampant.

In part 2 of a roundtable on the Most Favored Nation Executive Order for prescription drugs, experts gathered to discuss recent developments and how they’ll impact the policy’s future.

From verifying vaccination status to administering immunizations, pharmacists can mitigate the spread of various infectious diseases.

As shortages end, pharmacies that compound GLP-1s face lawsuits, stricter board oversight, and tougher FDA enforcement.

Pharmacists can help patients maintain muscle mass, meet their protein needs, and prevent nutritional deficiencies through evidence-based guidance that supports better overall health.

A collection of 4 major independent pharmacy groups filed an amicus brief urging Iowa representatives to shut down a recent challenge to proposed PBM legislation.

With uncertainty in dosing recommendations, researchers aim to assess the efficacy of pneumococcal conjugate vaccines for the pediatric population.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, discusses why the underutilization of technology could be hurting pharmacy businesses.

Celebrate the vital role of pharmacists in health care this American Pharmacists Month.

Further, they found weight loss prior to 75-g oral glucose tolerance test was a preventive factor for both impaired glucose tolerance and diabetes.

Amgen launches AmgenNow, which is a new direct-to-patient program that will start with evolucumab.

As the sixth approval for roflumilast in less than 4 years, the cream is expected to impact the 1.8 million children who have reported atopic dermatitis.

Researchers conduct a pilot study that assesses clinical pharmacists’ interventions and management of chronic diseases for older adults living in senior housing facilities.

Prior to the government shutdown, the FDA approved a generic version of mifeprisone without a public announcement.

Significant patient reports show a lack of response to treatment for community-acquired pneumonia, leading researchers to investigate the use of corticosteroids.

Ashley Moose, PharmD, owner of Moose Pharmacy of Monroe and director of network development at CPESN USA, capped off this fall’s event and discussed where to access sessions on demand.

This is the first Bruton tyrosine kinase inhibitor FDA approved for chronic spontaneous urticaria.

This month, Drug Topics® explores a new avenue of pharmacy each week, including AI technology, student education, innovative community services, and the expansion of clinical care.

Amid ongoing approaches to lower drug prices for US patients, like the Most-Favored-Nation policy, this is another partnership the Trump Administration believes will improve access challenges.

In part 2 of our interview, Lissette Logan, PharmD, and Danielle Weaver, PharmD, discuss the evolution of contraceptive services and how pharmacy is supporting rural communities and their patients.

In part 3 of our interview with Bill Wolfe, COO of WriteWise, he discusses the technology backing his team’s approach to forever changing how pharmacy benefits are distributed in the US.

Since 2016, the rate of gabapentin prescribing slowed but is still increasing, especially for women and older adults.

This marks the first and only IL-23 approval for these indications in pediatric populations.

Amid recent measles outbreaks in Texas and Ohio, researchers aim to understand MMR vaccine coverage following postelimination outbreaks throughout the country.

Based on a new report detailing the current trends in PBM types from the Big 3 to new grassroots organizations, Bill Wolfe, COO of WriteWise, discusses a shifting pharmacy benefits landscape.